ArticleCureus2017

Somatostatin Receptor Avidity in Gastrointestinal Stromal Tumors: Theranostic Implications of Gallium-68 Scan and Eligibility for Peptide Receptor Radionuclide Therapy.

Arturo Loaiza-Bonilla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.